The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Inhibition of nitric-oxide synthase 2 by aminoguanidine provides neuroprotection of retinal ganglion cells in a rat model of chronic glaucoma
Open accessAbstract
Glaucoma is an optic neuropathy with cupping of the optic disk, degeneration of retinal ganglion cells, and characteristic visual field loss. Because elevated intraocular pressure (IOP) is a major risk factor for progression of glaucoma, treatment has been based on lowering IOP. We previously demonstrated inducible nitric-oxide synthase (NOS-2) in the optic nerve heads from human glaucomatous eyes and from rat eyes with chronic, moderately elevated IOP. Using this rat model of unilateral glaucoma, we treated a group of animals for 6 months with aminoguanidine, a relatively specific inhibitor of NOS-2, and compared them with an untreated group. At 6 months, untreated animals had pallor and cupping of the optic disks in the eyes with elevated IOP. Eyes of aminoguanidine-treated animals with similar elevations of IOP appeared normal. We quantitated retinal ganglion cell loss by retrograde labeling with Fluoro-Gold. When compared with their contralateral control eyes with normal IOP, eyes with elevated IOP in the untreated group lost 36% of their retinal ganglion cells; the eyes with similarly elevated IOP in the aminoguanidine-treated group lost less than 10% of their retinal ganglion cells. Pharmacological neuroprotection by inhibition of NOS-2 may prove useful for the treatment of patients with glaucoma.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Advanced protein glycosylation in diabetes and aging
Brownlee, M. D. (1995) · Annual Review of Medicine · doi:10.1146/annurev.med.46.1.223 · Cited by 1,312
Optic Nerve Damage in Human Glaucoma: II. The Site of Injury and Susceptibility to Damage
Quigley, H. A. (1981) · Archives of Ophthalmology · doi:10.1001/archopht.1981.03930010635009 · Cited by 1,244
Aminoguanidine Prevents Diabetes-Induced Arterial Wall Protein Cross-Linking
Brownlee, M., Vlassara, H., Kooney, A., Ulrich, P., & Cerami, A. (1986) · Science · doi:10.1126/science.3487117 · Cited by 1,146
Retinal ganglion cell death in experimental glaucoma and after axotomy occurs by apoptosis.
Quigley, H. A., Nickells, R. W., Kerrigan, L. A., Pease, M. E., Thibault, D., & Zack, D. J. (1995) · PubMed · Cited by 935
Aminoguanidine, a Novel Inhibitor of Nitric Oxide Formation, Prevents Diabetic Vascular Dysfunction
Corbett, J. A., Tilton, R. G., Chang, K., Hasan, K. S., Ido, Y., Wang, J. L., Sweetland, M. A., Lancaster, J. R., Williamson, J. R., & McDaniel, M. L. (1992) · Diabetes · doi:10.2337/diab.41.4.552 · Cited by 628
Di Polo, A., Aigner, L. J., Dunn, R. J., Bray, G. M., & Aguayo, A. J. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.7.3978 · Cited by 430
Nitric Oxide Synthase in the Human Glaucomatous Optic Nerve Head
Neufeld, A. H. (1997) · Archives of Ophthalmology · doi:10.1001/archopht.1997.01100150499009 · Cited by 342
Self-citationChronic ocular hypertension following episcleral venous occlusion in rats
Shareef, S. R., Garcia-Valenzuela, E., Salierno, A., Walsh, J., & Sharma, S. C. (1995) · Experimental Eye Research · doi:10.1016/s0014-4835(05)80131-9 · Cited by 299
Sellés-Navarro, I., Villegas‐Pérez, M. P., Salvador‐Silva, M., Ruiz-Gómez, J. M., & Vidal‐Sanz, M. (1996) · PubMed · Cited by 272
Medical Management of Glaucoma
Alward, W. L. M. (1998) · New England Journal of Medicine · doi:10.1056/nejm199810293391808 · Cited by 252
Cited by
The impact of ocular blood flow in glaucoma
Flammer, J., Orgül, S., Costa, V. P., Orzalesi, N., Krieglstein, G. K., Serra, L. M., Renard, J.-P., & Stefánsson, E. (2002) · Progress in Retinal and Eye Research · doi:10.1016/s1350-9462(02)00008-3 · Cited by 1,709
Retinal ischemia: mechanisms of damage and potential therapeutic strategies
Osborne, N. N., Casson, R. J., Wood, J. P. M., Chidlow, G., Graham, M., & Melena, J. (2004) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2003.12.001 · Cited by 1,056
Mitochondrial dysfunction as a cause of optic neuropathies
Carelli, V., Ross-Cisneros, F. N., & Sadun, A. A. (2004) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2003.10.003 · Cited by 839
Oxidative stress in glaucomatous neurodegeneration: Mechanisms and consequences
Tezel, G. (2006) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2006.07.003 · Cited by 723
The optic nerve head in glaucoma: role of astrocytes in tissue remodeling
Hernandez, M. R. (2000) · Progress in Retinal and Eye Research · doi:10.1016/s1350-9462(99)00017-8 · Cited by 570
Inducible Nitric Oxide Synthase and Inflammatory Diseases
Zamora, R., Vodovotz, Y., & Billiar, T. R. (2000) · Molecular Medicine · doi:10.1007/bf03401781 · Cited by 558
Definition of glaucoma: clinical and experimental concepts
Casson, R. J., Chidlow, G., Wood, J. P., Crowston, J. G., & Goldberg, I. (2012) · Clinical & Experimental Ophthalmology · doi:10.1111/j.1442-9071.2012.02773.x · Cited by 510
Tezel, G., & Wax, M. B. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-23-08693.2000 · Cited by 395
Microglia in Retinal Degeneration
Rashid, K., Akhtar-Schaefer, I., & Langmann, T. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01975 · Cited by 355
Nickells, R. W., Howell, G. R., Soto, I., & John, S. W. M. (2012) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.051508.135728 · Cited by 336
Yuan, L., & Neufeld, A. H. (2000) · Glia · doi:10.1002/1098-1136(200010)32:1<42::aid-glia40>3.0.co;2-3 · Cited by 325
Self-citationProduction of nitric oxide by glial cells: Regulation and potential roles in the CNS
Murphy, S. (2000) · Glia · doi:10.1002/(sici)1098-1136(20000101)29:1<1::aid-glia1>3.0.co;2-n · Cited by 314
Nitric oxide: Ocular blood flow, glaucoma, and diabetic retinopathy
TODA, N., & NAKANISHITODA, M. (2007) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2007.01.004 · Cited by 311
Schori, H., Kipnis, J., Yoles, E., WoldeMussie, E., Ruiz, G., Wheeler, L. A., & Schwartz, M. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.041609498 · Cited by 286
Schmidl, D., Garhofer, G., & Schmetterer, L. (2011) · Experimental Eye Research · doi:10.1016/j.exer.2010.09.002 · Cited by 282
Matrix Metalloproteinases and Tumor Necrosis Factor α in Glaucomatous Optic Nerve Head
Yan, X. (2000) · Archives of Ophthalmology · doi:10.1001/archopht.118.5.666 · Cited by 266
Retinal Oxidative Stress Induced by High Intraocular Pressure
Moreno, M. C., Campanelli, J., Sande, P., Sáenz, D. A., Keller Sarmiento, M. I., & Rosenstein, R. E. (2004) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2004.06.001 · Cited by 265
TNF-α signaling in glaucomatous neurodegeneration
Tezel, G. (2008) · Progress in Brain Research · doi:10.1016/s0079-6123(08)01128-x · Cited by 261
Understanding mechanisms of pressure-induced optic nerve damage
Morrison, J. C., Johnson, E. C., Cepurna, W., & Jia, L. (2005) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2004.08.003 · Cited by 261
Retinal Ischemia and Reperfusion Causes Capillary Degeneration: Similarities to Diabetes
Zheng, L., Gong, B., Hatala, D. A., & Kern, T. S. (2007) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.06-0510 · Cited by 257
Effect of CNTF on retinal ganglion cell survival in experimental glaucoma
Pease, M. E., Zack, D. J., Berlinicke, C., Bloom, K., Cone, F., Wang, Y., Klein, R. L., Hauswirth, W. W., & Quigley, H. A. (2009) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.08-3013 · Cited by 222
Sildenafil-associated nonarteritic anterior ischemic optic neuropathy
Pomeranz, H. D., Smith, K. H., Hart, W. M., & Egan, R. A. (2002) · Ophthalmology · doi:10.1016/s0161-6420(01)00976-9 · Cited by 173
Neuroprotection in Glaucoma: Animal Models and Clinical Trials
Almasieh, M., & Levin, L. A. (2017) · Annual Review of Vision Science · doi:10.1146/annurev-vision-102016-061422 · Cited by 111
“For example, a study of the use of the inducible nitric oxide synthase inhibitor 2– aminoguanidine in rat glaucoma showed different results, depending on exactly how the IOP was raised in the rodent (Neufeld et al. 1999, Pang et al. 2005).”
Background
Metadata
- Authors
- Neufeld, A. H., Sawada, A., & Becker, B.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1999-08-17
- Volume
- 96
- Issue
- 17
- Pages
- 9944-9948
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2122477596
- Cited by
- 374
- References
- 19
- FWCI
- 23.05
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.